A Brazilian crossover study found that children and caregivers strongly prefer extraoral over intraoral photobiomodulation ...

argenx SE ( ARGX ), an immunology company, on Thursday reported positive Phase 2 results for FB102 in celiac disease and separately announced that it will discontinue the Phase 3 UNITY study of ...

Smelling freshly brewed coffee for five minutes was linked to lower fatigue, anxiety and tension in 20 healthy adults, a ...

Study met primary endpoint of change from baseline in the ratio of Vh:Cd (p=0.0176)First Phase 2 evidence that blocking CD122 can prevent gluten-induced intestinal damage in people living with celiac ...

, Oct. 8 -- A commonly used vitamin D supplement may have an unexpected effect on the body, with research suggesting that vitamin D2 can reduce levels of vitamin D3, the form naturally produced when ...

Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo") announced the successful submission of a Phase Ⅰ Clinical Trial Application (CTA ...

AM CETAmsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, today ...

Treating individual metastatic tumors with highly focused radiation or surgery did not improve progression-free or overall survival for patients with oligometastatic breast cancer receiving first-line ...

"The fact that CDC leadership is now advocating for RFK Jr.'s unethical and deeply disturbing vaccine trial is a new low for an agency that has been fundamentally compromised by the Secretary's work ...

A two-year randomized trial found that diet drinks with aspartame, sucralose and acesulfame potassium matched water for ...

Based on the strength of results from the Phase 2 ZUPREME-1 and ZUPREME-2 trials, Zealand and Roche have initiated three separate Phase 3 studies, namely ZUPREME-3, ZUPREME-4, and ZUPREME-5. The ...